Ipsen S.A. IPSEY
Set alert
44.46 USD +0.11 +0.24%
At close · Oct 30
42.70 Day range 42.76
34.34 52-week range 50.70
- YTD
- +22.28%
- 1 year
- +25.53%
- Open
- 42.76
- Prev close
- 44.35
- Mkt cap
- 14.66B
- Vol
- 50
- Avg vol
- 1.16K
- EPS
- 1.81
- P/E
- 24.56
More statistics
- Low
- 42.70
- High
- 42.76
- Earnings
- Feb 11, 2027
Next earnings
Feb 11, 2027
Expected Feb 11, 2027. Consensus EPS estimate 2.06.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 11, 2027 | Dec 30, 2026 | 2.06 | — | — | — |
| Jul 30, 2026 | Jun 30, 2026 | 1.86 | 2.11 | +0.25 | +13.44% |
| Feb 12, 2026 | Dec 31, 2025 | 1.64 | 1.79 | +0.15 | +9.15% |
| Jul 31, 2025 | Jun 30, 2025 | 1.63 | 1.74 | +0.11 | +6.75% |
| Feb 13, 2025 | Dec 31, 2024 | — | 1.44 | — | — |
| Jul 25, 2024 | Jun 30, 2024 | 1.26 | 1.30 | +0.04 | +3.17% |
News
- Ipsen S.A. (IPSEY) Q2 2026 Sales/Trading Call Transcript
- IPSEN (OTCMKTS:IPSEY) Shares Gap Down – Should You Sell?
- IPSEN (OTCMKTS:IPSEY) Given Consensus Rating of “Hold” by Analysts
- Ipsen S.A. (IPSEY) Q2 2026 Earnings Call Transcript
- Ipsen S.A. (IPSEY) Discusses Phase II LANTIC Data and Innovation in Engineered Neuroinhibitors for Aesthetic Indications Transcript
- Annual General Meeting of Ipsen S.A. held on 13 May 2026
- Ipsen S.A. – Evolution of the composition of the Board of Directors
- Ipsen S.A. (IPSEY) Q1 2026 Earnings Call Transcript
- IPSEN (OTCMKTS:IPSEY) Shares Cross Above Two Hundred Day Moving Average – Should You Sell?
- Ipsen S.A. publishes its 2025 Consolidated Financial Statements
Your note
Sign in to keep a note on IPSEY — it syncs with the Stock Master app.